Pontifax

Clinical-stage immunology company developing ANV419.

#BioPharma

Developing therapies for viral diseases.

#BioPharma

Research and development of targeted therapeutics; acquired by Merck.

#BioPharma

Develops angiogram-based FFR (FFRangio) for coronary catheterization.

#Medical Devices

Developed immunotherapies for cancer; lead agent CM-24; acquired by Merck in July 2015.

#BioPharma

Developing an ingestible pill for colorectal cancer screening that avoids bowel prep.

#Medical Devices

Applies computational cell-level models to advance pharmaceutical R&D.

#Digital Health

Developing antisense drugs for Centronuclear Myopathies (CNM).

#BioPharma

Develops compounds for genetic diseases caused by nonsense mutations.

#BioPharma

European ADC company; lead program targets Nectin-4; acquired by Lilly in 2023.

#BioPharma

Developing cell-based therapies for immune tolerance; lead program in graft-versus-host disease.

#BioPharma

Develops non-viral gene therapy treatments for ophthalmology.

#BioPharma

Develops medical devices for treatment of corneal edema.

#Medical Devices

Identifies tumor-specific driver mutations using a functional assay.

#BioPharma

Developing an accommodating intraocular lens for post-cataract surgery.

#MedTech

Developing selective ROCK2 inhibitors; lead asset GV101 for fibrotic and autoimmune indications.

#BioPharma

Developing mitochondrial replaced cells therapy for mitochondrial disorders.

#BioPharma

Clinical-stage company focused on selective oral immunology therapies.

#BioPharma

Developing small molecule TRPV3 inhibitors for dermatological conditions.

#BioPharma

Focused on treatments for rare muscle diseases; lead program for FOP.

#BioPharma

Developed engineered autologous T-cell therapies; sold to Gilead.

#BioPharma

Development-stage company commercializing improved versions of CNS treatments.

#BioPharma

Developing topical oxymetazoline for cosmetic eye lifts.

#BioPharma

Developing GeneRide gene therapy platform for rare diseases.

#BioPharma

Developing LUT014, a topical B-Raf inhibitor to manage EGFR inhibitor side effects.

#BioPharma

Develops therapies for oncology and rare diseases.

#BioPharma

Drug discovery in cancer metabolism using computational biology and metabolomics.

#BioPharma

Developing targeted cancer therapies.

#BioPharma

Developing drug-device bioconvergence platform to deliver drugs to the uterus with a 3D carrier.

#MedTech

Develops medicines for addiction and drug overdose.

#BioPharma

Developing ophthalmic therapies for retinal vascular disorders.

#Debt

Develops personalized T cell therapies targeting neo-antigens.

#BioPharma

Develops radiopharmaceuticals using camelid-derived single-domain antibodies.

#BioPharma

Developed gene therapies for Parkinson’s and other neurodegenerative diseases; acquired by Lilly.

#BioPharma

RNA therapeutics platform focused on rare inherited retinal diseases.

#BioPharma

Manufactures recombinant therapeutic proteins using a plant cell-based expression system (ProCellEx).

#BioPharma

Clinical-stage company developing a drug for local fat reduction (obesity-related indications).

#BioPharma

Develops a robotic exoskeleton system for individuals with lower limb disabilities.

#MedTech

Developing RyR1/2 modulators for cardiac, musculoskeletal and neurological disorders.

#BioPharma

Rare disease company focused on CNS treatments.

#BioPharma

Develops next-generation antibody-drug conjugates for immuno-oncology.

#BioPharma

Late-stage biopharmaceutical company focused on rare diseases.

#BioPharma

Ophthalmic biotech focused on treatments for Stargardt’s disease.

#BioPharma

Developing small molecule therapeutics for autoimmune diseases.

#BioPharma

Developing Artificial Ostomy Sphincter (Stimatix GI AOS) products.

#MedTech

Novel gene therapy pipeline targeting rare disorders.

#Biopharma

Telemedicine platform for outcome prediction and clinical intervention in diabetics.

#Mobile Health

Develops microbiome-based treatments for eating disorders and weight management.

#BioPharma

Clinical-stage specialty pharmaceutical company focused on sustained-release formulations for uro-oncology.

#BioPharma

Developed a catheter-implanted miniature valve to reduce cardiac chamber pressure in certain patients.

#MedTech

Founded 2019; developing therapies for neurodegenerative diseases, including programs targeting GCase for Parkinson’s disease.

#BioPharma

Develops technologies for coronary and peripheral revascularization surgeries.

#Medical Devices

Commercial-stage company developing next-generation vaccines for infectious diseases and immuno-oncology.

#BioPharma